139 related articles for article (PubMed ID: 34493474)
21. Langerhans cell counts in oral epithelial dysplasia and their correlation to clinicopathological parameters.
Wang YP; Chen IC; Wu YH; Wu YC; Chen HM; Yu-Fong Chang J
J Formos Med Assoc; 2017 Jun; 116(6):457-463. PubMed ID: 28292622
[TBL] [Abstract][Full Text] [Related]
22. Whole-exome sequencing of oral epithelial dysplasia samples reveals an association with new genes.
Adorno-Farias D; Santos JND; González-Arriagada W; Tarquinio S; Santibáñez Palominos RA; Martín Martín AJ; Fernandez-Ramires R
Braz Oral Res; 2023; 37():e016. PubMed ID: 36790257
[TBL] [Abstract][Full Text] [Related]
23. Outcome of oral dysplasia: a retrospective hospital-based study of 207 patients with a long follow-up.
Arduino PG; Surace A; Carbone M; Elia A; Massolini G; Gandolfo S; Broccoletti R
J Oral Pathol Med; 2009 Jul; 38(6):540-4. PubMed ID: 19453839
[TBL] [Abstract][Full Text] [Related]
24. Why oral histopathology suffers inter-observer variability on grading oral epithelial dysplasia: an attempt to understand the sources of variation.
Kujan O; Khattab A; Oliver RJ; Roberts SA; Thakker N; Sloan P
Oral Oncol; 2007 Mar; 43(3):224-31. PubMed ID: 16931119
[TBL] [Abstract][Full Text] [Related]
25. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma].
Cao J; Jin JQ; Deng DJ; Liu HW
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914
[TBL] [Abstract][Full Text] [Related]
26. Several tetratricopeptide repeat (TPR) motifs of FANCG are required for assembly of the BRCA2/D1-D2-G-X3 complex, FANCD2 monoubiquitylation and phleomycin resistance.
Wilson JB; Blom E; Cunningham R; Xiao Y; Kupfer GM; Jones NJ
Mutat Res; 2010 Jul; 689(1-2):12-20. PubMed ID: 20450923
[TBL] [Abstract][Full Text] [Related]
27. FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3.
Wilson JB; Yamamoto K; Marriott AS; Hussain S; Sung P; Hoatlin ME; Mathew CG; Takata M; Thompson LH; Kupfer GM; Jones NJ
Oncogene; 2008 Jun; 27(26):3641-52. PubMed ID: 18212739
[TBL] [Abstract][Full Text] [Related]
28. Histopathological findings of oral epithelial dysplasias and their relation to malignant transformation.
Ellonen R; Suominen A; Kelppe J; Willberg J; Rautava J; Laine H
Cancer Treat Res Commun; 2023; 34():100664. PubMed ID: 36481601
[TBL] [Abstract][Full Text] [Related]
29. Malignant transformation in 5071 southern Taiwanese patients with potentially malignant oral mucosal disorders.
Wang YY; Tail YH; Wang WC; Chen CY; Kao YH; Chen YK; Chen CH
BMC Oral Health; 2014 Aug; 14():99. PubMed ID: 25096230
[TBL] [Abstract][Full Text] [Related]
30. Readdressing dysplasia at surgical margins as predictive biomarker of malignant transformation.
Sarode GS; Sarode SC; Sengupta N; Sharma NK; Patil S
Oral Oncol; 2021 Jun; 117():105181. PubMed ID: 33500183
[TBL] [Abstract][Full Text] [Related]
31. Characterization of epithelial oral dysplasia in non-smokers: First steps towards precision medicine.
Rock LD; Rosin MP; Zhang L; Chan B; Shariati B; Laronde DM
Oral Oncol; 2018 Mar; 78():119-125. PubMed ID: 29496039
[TBL] [Abstract][Full Text] [Related]
32. A correlation of immunohistochemical expression of
Pandya JA; Boaz K; Natarajan S; Manaktala N; Nandita KP; Lewis AJ
J Cancer Res Ther; 2018; 14(3):666-670. PubMed ID: 29893337
[TBL] [Abstract][Full Text] [Related]
33. Biological significance of 5-hydroxymethylcytosine in oral epithelial dysplasia and oral squamous cell carcinoma.
Cuevas-Nunez MC; Gomes CBF; Woo SB; Ramsey MR; Chen XL; Xu S; Xu T; Zhan Q; Murphy GF; Lian CG
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jan; 125(1):59-73.e2. PubMed ID: 28743666
[TBL] [Abstract][Full Text] [Related]
34. Evolution tumour models paving the way for understanding oral carcinogenesis.
Martins-Chaves RR; Silva RSO; Pereira TDSF; Fonseca FP; Gomez RS
J Oral Pathol Med; 2023 Apr; 52(4):294-299. PubMed ID: 36622735
[TBL] [Abstract][Full Text] [Related]
35. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England.
Warnakulasuriya S; Kovacevic T; Madden P; Coupland VH; Sperandio M; Odell E; Møller H
J Oral Pathol Med; 2011 Oct; 40(9):677-83. PubMed ID: 21762430
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical Evaluation of GLUT-3 and GLUT-4 in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Feitosa SG; Viana KF; Luna ECM; Costa FWG; Cavalcante RB; Chaves FN; Chaves HV; Pereira KMA
Asian Pac J Cancer Prev; 2018 Jul; 19(7):1779-1783. PubMed ID: 30049187
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional analysis highlights three distinct immune profiles of high-risk oral epithelial dysplasia.
Gan CP; Lee BKB; Lau SH; Kallarakkal TG; Zaini ZM; Lye BKW; Zain RB; Sathasivam HP; Yeong JPS; Savelyeva N; Thomas G; Ottensmeier CH; Ariffin H; Cheong SC; Lim KP
Front Immunol; 2022; 13():954567. PubMed ID: 36119104
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology and correlation of the clinicopathological features in oral epithelial dysplasia: analysis of 173 cases.
Pereira Jdos S; Carvalho Mde V; Henriques AC; de Queiroz Camara TH; Miguel MC; Freitas Rde A
Ann Diagn Pathol; 2011 Apr; 15(2):98-102. PubMed ID: 21190879
[TBL] [Abstract][Full Text] [Related]
39. Malignant Transformation of Fanconi Anemia Complementation Group D2-deficient (
Zhang X; Fisher R; Shields D; Hou W; Franicola D; Wang H; Epperly MW; Rigatti L; Greenberger JS
In Vivo; 2019; 33(2):303-311. PubMed ID: 30804107
[TBL] [Abstract][Full Text] [Related]
40. Oral epithelial dysplasia in non-users of tobacco and alcohol: an analysis of clinicopathologic characteristics and treatment outcome.
Jaber MA
J Oral Sci; 2010 Mar; 52(1):13-21. PubMed ID: 20339228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
